NCT00276107View on ClinicalTrials.gov

Study Evaluating Prevenar Vaccine in Healthy Infants

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

December 31, 2004

Study Completion Date

December 31, 2005

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL

Prevenar

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00276107 - Study Evaluating Prevenar Vaccine in Healthy Infants | Biotech Hunter | Biotech Hunter